Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7176619 | 0.80 | MEN1 (0.34) | MEN1MAPTHTTKMT2A | |
| SCHEMBL21974636 | 0.80 | LMNA (0.32) | — | |
| SCHEMBL12309889 | 0.80 | LMNA (0.32) | — | |
| SCHEMBL14986201 | 0.74 | — | — | |
| SCHEMBL12251088 | 0.74 | — | — | |
| SCHEMBL188694 | 0.72 | MEN1 (0.41) | MEN1MAPTHTTKMT2A | |
| SCHEMBL2650044 | 0.71 | — | — | |
| SCHEMBL3834812 | 0.71 | — | — | |
| SCHEMBL164556 | 0.71 | — | — | |
| SCHEMBL443601 | 0.69 | MEN1 (0.46) | MEN1MAPTHTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| CN-114933591-B | Pyridine derivative and application thereof | 北京鼎材科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-110407810-B | Organic electroluminescent material and application thereof | 北京鼎材科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-114933591-A | Pyridine derivatives and use thereof | 北京鼎材科技有限公司 | 2022-08-23 | — | — | CN | disclosed |
| CN-110491999-B | Modification method of electron transport layer for organic solar cell | 太原理工大学 | 2022-04-12 | — | — | CN | disclosed |
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-09-30 | — | — | US | disclosed |
| WO-2021080508-A1 | METHOD AND SYSTEM FOR SYNTHESISING COMPOUNDS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2021-04-29 | — | — | WO | disclosed |
| CN-110872298-A | Condensed ring aryl compound, organic electronic device and application thereof | 宁波卢米蓝新材料有限公司 | 2020-03-10 | — | — | CN | disclosed |
| US-5693646-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5693647-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-12-02 | — | — | US | disclosed |
| US-5688808-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| US-5688810-A | Steroid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0800519-A1 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS, INC. (US) | 1997-10-15 | — | — | EP | disclosed |
| US-5674880-A | ANTIINFLAMMATORY AGENT | CELLTECH THERAPEUTICS LIMITED (GB) | 1997-10-07 | — | — | US | disclosed |
| WO-1996019458-A2 | STEROID RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1996-06-27 | — | — | WO | disclosed |
| US-5491147-A | PHOSPHODIESTERASE IV INHIBITORS | CELLTECH, LIMITED (GB) | 1996-02-13 | — | — | US | disclosed |
| EP-0618889-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CELLTECH THERAPEUTICS LIMITED (GB) | 1994-10-12 | — | — | EP | disclosed |
| WO-1994010118-A1 | TRI-SUBSTITUTED PHENYL DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CELLTECH LIMITED (GB) | 1994-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | OPRD1, DRD1, DRD3 | MEN1 3613/4885MAPT 600/4885HTT 3293/4885 |
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | OPRD1, DRD1, DRD3 | MEN1 3613/4885MAPT 600/4885HTT 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.